Health Condition 1: null- Migraine
Conditions
Interventions
Intervention1: Habb-e-Quqaya: 3 gram orally daily in two divided doses
Control Intervention1: Not Applicable: Not Applicable
Sponsors
National Institute of Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: Patients clinically diagnosed according to ICHD criteria Patients between 18-60 years of age Patients of either gender Willing to complete daily dairy Willing to take medication for 45 days
Exclusion criteria
Exclusion criteria: Patients below 18 and above 60 years of age Pregnancy and lactation Major Systemic disorders Patients with known psychiatric and mental disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| reduction in Headache frequency (From the daily headache diary) Reduction in MIDAS (Migraine disability assessment) score Reduction in Headache intensity by VAS (Visual analogue scale) Timepoint: before treatment, 15th day, 30th day, 45th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in Headache (Unilateral or Bilateral) &/ (Pulsating or non pulsating quality) Nausea vomiting Photophobia Phonophobia Timepoint: Before treatment, 15th day, 30th day, 45th day | — |
Countries
India
Contacts
Public ContactDr Muzaffar Din Ahmad Bhat
National Institute of Unani Medicine
Outcome results
None listed